Scholar Rock to Develop SRK-015 to Improve Muscle Function in Patients with Spinal Muscular Atrophy

First data on inhibition of myostatin activation in a preclinical model of SMA to be highlighted at the Cure SMA Annual Conference Treatment with SRK-015 resulted in significantly increased muscle strength in a genetic model of SMA CAMBRIDGE, Mass., June 28, 2017 – Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively […]